Dynatronics Corp. (NASDAQ:DYNT) shares decreased -2.64% in last trading session and ended the day at $2.95. DYNT Gross Margin is 30.70% and its has a return on assets of -30.00%. Dynatronics Corp. (NASDAQ:DYNT) quarterly performance is -1.67%.
On 13 November, Dynatronics Corp. (NASDAQ:DYNT) announced financial and operating results for its fiscal 2016 first quarter ended September 30, 2015. Net sales for the fiscal first quarter were $7.4 million, a 2.5% increase compared to $7.2 million in the same period of the prior year. Gross margin for the fiscal first quarter was 33.9% compared to 35.6% for the quarter ended September 30, 2014, reflecting higher sales of distributed products which carry lower than average margins.
Computer Programs & Systems Inc. (NASDAQ:CPSI) ended the last trading day at $39.87. Company weekly volatility is calculated as 2.57% and price to cash ratio as 11.73. Computer Programs & Systems Inc. (NASDAQ:CPSI) showed a weekly performance of -1.48%.
Computer Programs & Systems Inc. (NASDAQ:CPSI) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.64 (sixty-four cents) per share, payable on November 27, 2015, to stockholders of record as of the close of business on November 12, 2015.
On 16 November, The Cato Corporation (NYSE:CATO) shares increased 1.06% and was closed at $37.35. CATO EPS growth in last 5 year was 7.00%. The Cato Corporation (NYSE:CATO) year to date (YTD) performance is -9.33%.
On 5 November, The Cato Corporation (NYSE:CATO) reported sales for the four weeks ended October 31, 2015 of $73.2 million, a 4% increase over sales of $70.5 million for the four week period ended November 1, 2014. Same-store sales for the month increased 1%.
Radius Health, Inc. (NASDAQ:RDUS) shares decreased -7.28% in last trading session and ended the day at $69.18. RDUS has a return on assets of -31.70%. Radius Health, Inc. (NASDAQ:RDUS) quarterly performance is -2.86%.
Radius Health, Inc. (NASDAQ:RDUS) said that, it will present at the Goldman Sachs U.S. Emerging/SMID Cap Growth Conference at 3:50 p.m. Nov. 19 in New York.
Arrowhead Research Corp. (NASDAQ:ARWR) caters to the Healthcare space. Its weekly performance is 5.72%. On the last day of trading company shares ended up at $5.73. Arrowhead Research Corp. (NASDAQ:ARWR) distance from 50-day simple moving average (SMA50) is -3.67%.
Arrowhead Research Corp. (NASDAQ:ARWR) presented data from a Phase 2a clinical study at The AASLD Liver Meeting 2015®demonstrating that ARC-520, its lead drug candidate against chronic hepatitis B infection (HBV), effectively reduced HBV viral antigens derived from cccDNA. HBV surface antigen (HBsAg) was reduced substantially with a maximum reduction of 1.9 logs (99%) and a mean maximum reduction of 1.5 logs (96.8%) in treatment naïve e-antigen (HBeAg)-positive patients.
Leave a Reply